Abstract 422 Table 2

Impact of LT on HRQL stratified by ECMO status at 6 months adjusted for pre-LT age, sex, diagnosis, LAS, pre-LT FEV1 and 6MWD

ECMO (n=17)
Change (95% CI)
Inpatient w/o ECMO (n=41)
Change (95% CI)
Outpatient (n=119)
Change (95% CI)
P-value
SF-12 PCS18.1 (13.1, 23.2)18.6 (13.8, 23.5)21.0 (18.5, 23.4)0.592
AQ20–4r8.6 (6.2, 11.1)8.6 (6.7, 10.5)8.8 (7.8, 9.7)0.975
EQ5D0.27 (0.15, 0.39)0.24 (0.16, 0.32)0.16 (0.12, 0.19)0.028